Envista Holdings Corp (NVST)
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.
Sector: Dental Equipment & Supplies
Industry: Medical - Instruments & Supplies
Envista Holdings Corp
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 160.62M shares outstanding
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions.
The company is headquartered in Brea, California and currently employs 12,800 full-time employees.
The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone.
The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables.
Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products.
Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
Leadership
Paul Keel
President, CEO & Chairman
Eric D. Hammes
Senior Vice President & Chief Financial Officer
Veronica Acurio
Senior Vice President & President of Orthodontics
Mark E. Nance
Senior Vice President, General Counsel & Secretary
Employees
12K+
Country
US
Sector
Healthcare
Website
envistaco.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| President, Orthodontics | Automatic Sell | 7.7K | $211.8K | Aug 25, 2026 | |
| President, Nobel Biocare | Automatic Sell | 804 | $22.1K | Aug 25, 2026 | |
| Chief Financial Officer | Automatic Sell | 10.9K | $299.0K | Aug 25, 2026 | |
| President, Diagnostics | Automatic Sell | 5.1K | $141.4K | Aug 25, 2026 | |
| SVP, Strategy & Bus. Dev. | Sale | 8.0K | $220.0K | Aug 20, 2026 | |
| Chief Financial Officer | Grant/Award | 48.0K | -- | Aug 18, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
BlackRock, Inc. | 18.4M | 11.5% | 13F |
BlackRock, Inc. · also on 13F· may incl. warrants· filed Apr 2025 | 15.9M | 9.9% | 13G |
ARIEL INVESTMENTS, LLC | 9.8M | 6.1% | 13F |
DIMENSIONAL FUND ADVISORS LP | 9.6M | 6.0% | 13F |
VANGUARD PORTFOLIO MANAGEMENT LLC | 7.5M | 4.7% | 13F |
VANGUARD CAPITAL MANAGEMENT LLC | 7.3M | 4.6% | 13F |
Morgan Stanley · also on 13F· joint filing· may incl. warrants· filed May 2026 | 7.1M | 4.4% | 13G |
MORGAN STANLEY | 6.4M | 4.0% | 13F |
Gates Capital Management, Inc. | 5.6M | 3.5% | 13F |
STATE STREET CORP | 5.3M | 3.3% | 13F |
Insiders
- Acurio VeronicaPresident, Orthodontics
- Nilsson StefanPresident, Nobel Biocare
- Hammes Eric D.Chief Financial Officer
- Befidi RobertPresident, Diagnostics
- Reis MischaSVP, Strategy & Bus. Dev.
- Keel Paul AChief Executive Officer
- Pierce James AndrewDirector
- GALLAHUE KIERANDirector
- Raskas DanielDirector
- Huennekens R ScottDirector
based on 160.62M shares outstanding
30d Avg
2.75M
60d Avg
2.79M
90d Avg
2.92M